Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease

被引:4
作者
Gao, Chang [1 ]
Ding, Li [1 ]
Zhang, Xiaona [1 ]
Yuan, Menghua [1 ]
Tang, Shaofang [1 ]
Li, Wei [2 ]
Ye, Yuanyuan [1 ]
Liu, Ming [1 ]
He, Qing [1 ]
机构
[1] Tianjin Med Univ, Dept Endocrinol & Metab, Gen Hosp, Tianjin, Peoples R China
[2] Huazhong Univ Sci & Technol, Wuhan 1 Hosp, Tongji Med Coll, Dept Endocrinol, Wuhan, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
dehydroepiandrosterone sulfate (DHEA-S); serum steroids; mass spectrometry; orthogonal partial least squares discriminant analysis (OPLS-DA); Cushing syndrome; DEHYDROEPIANDROSTERONE-SULFATE; MS/MS; ASSAY; DIAGNOSIS; DHEAS;
D O I
10.3389/fendo.2023.1158573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDifferentiating between adrenal Cushing syndrome (adrenal CS) and Cushing disease (CD) can be challenging if there are equivocal or falsely elevated adrenocorticotropic hormone (ACTH) values. We aim to investigate the diagnostic value of serum steroid profiles in differentiating adrenal CS from CD. MethodA total of 11 serum steroids in adrenal CS (n = 13) and CD (n = 15) were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Age- and gender-specific steroid ratios were generated by dividing the actual steroid concentration by the upper limit of the relevant reference range. A principal component analysis (PCA) and an orthogonal partial least squares discriminant analysis (OPLS-DA) were performed. ResultsThe PCA and OPLS-DA analyses showed distinct serum steroid profiles between adrenal CS and CD. Dehydroepiandrosterone sulfate (DHEA-S), dehydroepiandrosterone (DHEA), and androstenedione ratios were identified as biomarkers for discrimination by variable importance in projection (VIP) in combination with t-tests. The sensitivity and specificity of DHEA-S ratios <0.40 were 92.31% (95% CI 64.0%-99.8%) and 93.33% (95% CI 68.1%-99.8%), respectively, in identifying adrenal CS. The sensitivity and specificity of DHEA ratios <0.18 were 100% (95% CI 75.3%-100.0%) and 100% (95% CI 78.2%-100.0%), respectively, in identifying adrenal CS. ConclusionOur data support the clinical use of the DHEA-S and DHEA ratios in the differential diagnosis of adrenal CS and CD, especially when falsely elevated ACTH is suspected.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome
    Masjkur, Jimmy
    Gruber, Matthias
    Peitzsch, Mirko
    Kaden, Denise
    Di Dalmazi, Guido
    Bidlingmaier, Martin
    Zopp, Stephanie
    Langton, Katharina
    Fazel, Julia
    Beuschlein, Felix
    Bornstein, Stefan Richard
    Reincke, Martin
    Eisenhofer, Graeme
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (10) : 4331 - 4340
  • [2] Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's
    Hirsch, Dania
    Shimon, Ilan
    Manisterski, Yossi
    Aviran-Barak, Nirit
    Amitai, Oren
    Nadler, Varda
    Alboim, Sandra
    Kopel, Vered
    Tsvetov, Gloria
    ENDOCRINE, 2018, 62 (03) : 712 - 720
  • [3] Limited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation between Adrenal Cushing Syndrome and Cushing Disease
    Hong, A. Ram
    Kim, Jung Hee
    Hong, Eun Shil
    Kim, I. Kyeong
    Park, Kyeong Seon
    Ahn, Chang Ho
    Kim, Sang Wan
    Shin, Chan Soo
    Kim, Seong Yeon
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (03) : 297 - 304
  • [4] Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome
    Prete, Alessandro
    Paragliola, Rosa Maria
    Bottiglieri, Filomena
    Rota, Carlo Antonio
    Pontecorvi, Alfredo
    Salvatori, Roberto
    Corsello, Salvatore Maria
    ENDOCRINE, 2017, 55 (03) : 969 - 980
  • [5] Steroid profiling in the diagnosis of mild and overt Cushing's syndrome
    Athimulam, Shobana
    Grebe, Stefan
    Bancos, Irina
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (01)
  • [6] Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome
    Alessandro Prete
    Rosa Maria Paragliola
    Filomena Bottiglieri
    Carlo Antonio Rota
    Alfredo Pontecorvi
    Roberto Salvatori
    Salvatore Maria Corsello
    Endocrine, 2017, 55 : 969 - 980
  • [7] Cushing syndrome due to adrenal carcinoma
    Jasmine Huynh
    Paul Aronowitz
    Journal of General Internal Medicine, 2018, 33 : 1203 - 1204
  • [8] Cushing syndrome due to adrenal carcinoma
    Huynh, Jasmine
    Aronowitz, Paul
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (07) : 1203 - 1204
  • [9] Adrenal Cushing's syndrome in children
    Guarnotta, Valentina
    Emanuele, Fabrizio
    Salzillo, Riccardo
    Giordano, Carla
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [10] Somatization Symptom and Steroid Myopathy in Cushing Syndrome with Adrenal Adenoma - A case report -
    Kim, Young Bum
    Hwang, Ji Hye
    Kim, Jun Seok
    Lee, Chang Hyung
    Kwon, Jung Yi
    ANNALS OF REHABILITATION MEDICINE-ARM, 2010, 34 (04): : 486 - 489